John Fair
2023
In 2023, John Fair earned a total compensation of $755.2K as Former Chief Commercial Officer at Cerulean Pharma, a 3% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $77,200 |
|---|---|
| Option Awards | $278,791 |
| Salary | $386,000 |
| Other | $13,200 |
| Total | $755,191 |
Fair received $386K in salary, accounting for 51% of the total pay in 2023.
Fair also received $77.2K in non-equity incentive plan, $278.8K in option awards and $13.2K in other compensation.
Rankings
In 2023, John Fair's compensation ranked 1,495th out of 2,907 executives tracked by ExecPay. In other words, Fair earned more than 48.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,495 out of 2,907 | 49th |
Division Manufacturing | 885 out of 1,599 | 45th |
Major group Chemicals And Allied Products | 569 out of 901 | 37th |
Industry group Drugs | 553 out of 864 | 36th |
Industry Pharmaceutical Preparations | 389 out of 622 | 38th |
Source: SEC filing on April 26, 2024.
Fair's colleagues
We found two more compensation records of executives who worked with John Fair at Cerulean Pharma in 2023.